MyFinsight
Home
Blog
About
Cash and cash
equivalents
$301,454K
(958.92%↑ Y/Y)
Short-term investments
$47,940K
(-57.91%↓ Y/Y)
Prepaid expenses and
other current assets
$2,741K
(-58.91%↓ Y/Y)
Other receivables
(including related party...
$141K
(370.00%↑ Y/Y)
Property and equipment
$15,454K
(10.01%↑ Y/Y)
Total current assets
$352,276K
(136.32%↑ Y/Y)
Operating lease
right-of-use assets
$9,236K
(-27.33%↓ Y/Y)
Property and equipment,
net
$5,671K
(-17.64%↓ Y/Y)
Other long-term
assets
$809K
(2028.95%↑ Y/Y)
Restricted cash
$461K
(0.00%↑ Y/Y)
Financing lease
right-of-use asset
$180K
(-22.08%↓ Y/Y)
Less accumulated
depreciation
$9,783K
(36.60%↑ Y/Y)
Total assets
$368,633K
(117.62%↑ Y/Y)
Total liabilities and
stockholders' equity
$368,633K
(117.62%↑ Y/Y)
Total stockholders'
equity
$347,502K
(133.16%↑ Y/Y)
Total liabilities
$21,131K
(3.84%↑ Y/Y)
Accumulated deficit
-$379,070K
(-31.51%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$21K
(-1150.00%↓ Y/Y)
Additional paid-in capital
$726,588K
(66.16%↑ Y/Y)
Total current
liabilities
$14,581K
(35.41%↑ Y/Y)
Operating lease
liabilities, net of current...
$6,550K
(-31.64%↓ Y/Y)
Common stock, 0.0001
par value...
$5K
(66.67%↑ Y/Y)
Accrued expenses
(including related party...
$9,896K
(69.51%↑ Y/Y)
Current portion of
operating lease...
$3,299K
(-6.70%↓ Y/Y)
Accounts payable
$1,386K
(14.07%↑ Y/Y)
Back
Back
Balance Sheet
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)
source: myfinsight.com